More than 1 million people in the United States are living with Parkinson’s disease, and this number continues to grow. That’s why innovations in Parkinson’s treatment are critical. We’re proud to partner with the Parkinson’s Foundation to help sponsor Moving Days across the country.
Deep brain stimulation (DBS) is a targeted therapy, which has been proven to manage the motor symptoms of Parkinson’s, reduce the need for medication1, and help improve the quality of life for many people2. Abbott’s exclusive, first-of-its kind3 remote programming platform enables your physician to make therapy adjustments from anywhere* so that you can focus on living your best life. Would you like to learn more?
1. Abbott. Data on File. Parkinson’s Disease Final Report C-04-01. 2012. n = 135.
2. Castrioto A. Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease. Archives of Nuerology, 2011;68(12):1550.n = 18.
3. Abbott. Data on File. First-of-its-Kind: US Virtual Clinic Neuromodulation Memo.
* Anywhere with a cellular or Wi-Fi connection and sufficiently charged patient controller.
MAT-2205851 v1.0 | Item approved for global use.
Links are provided is for convenience only, and is not an endorsement of either the linked-to entity or any product or service.
